Type of security: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
The data is delayed by 15 minutes.
NUVA is in the long-term up 152% in 11 years.
Description: NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for the spine. Its products focus on applications for spine fusion surgery. The company?s principal product offering includes a minimally disruptive surgical platform, known Maximum Access Surgery (MAS) that includes its proprietary software-driven nerve detection and avoidance systems, NVM5 and NVJJB, and intra-operative monitoring (IOM) support; MaXcess, an integrated split-blade retractor system; and various specialized implants. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company?s biologic product line offerings used to aid the spinal fusion process or bone healing consist of allograft (donated human tissue); Osteocel Plus, an allograft cellular matrix containing via
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||6.84%||Sales Growth - Q/Q||5.47%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||3.69%||ROE||7.11%||ROI||4.18%|
|Current Ratio||5.17||Quick Ratio||3.93||Long Term Debt/Equity||0.67||Debt Ratio||0.2|
|Gross Margin||76.15%||Operating Margin||15.49%||Net Profit Margin||6.01%||Dividend Payout Ratio|
|Cash From Financing Activities||-26.25 M||Cash From Investing Activities||-72.14 M||Cash From Operating Activities||35.18 M||Gross Profit||154.5 M|
|Net Profit||10.27 M||Operating Profit||25.86 M||Total Assets||1.29 B||Total Current Assets||684.33 M|
|Total Current Liabilities||132.44 M||Total Debt||368.5 M||Total Liabilities||618.32 M||Total Revenue||202.91 M|
|High 52 week||71.41||Low 52 week||44.53||Last close||60.98||Last change||-1.6%|
|RSI||52.12||Average true range||1.98||Beta||1||Volume||185.56 K|
|Simple moving average 20 days||0.26%||Simple moving average 50 days||5%||Simple moving average 200 days||2.38%|
|Performance Week||-1.45%||Performance Month||13.18%||Performance Quart||4.08%||Performance Half||5.52%|
|Performance Year||22.16%||Performance Year-to-date||23.04%||Volatility daily||1.92%||Volatility weekly||4.3%|
|Volatility monthly||8.81%||Volatility yearly||30.52%||Relative Volume||231.69%||Average Volume||588.92 K|
|New High||New Low|
2019-06-18 10:22:02 | NuVasive Grows on Strong Product Adoption Amid Pricing Woe
2019-06-18 07:27:11 | NuVasive Launches Titanium Spine Implant Modulus TLIF-O
2019-06-12 08:30:00 | NuVasive LessRay® Platform Wins Gold at 2019 Medical Design Excellence Awards
2019-06-10 08:06:13 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-05-31 09:31:01 | Why Is NuVasive NUVA Down 3.9% Since Last Earnings Report?
2019-05-30 08:06:06 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-05-29 09:47:51 | Is NuVasive, Inc. NASDAQ:NUVA A Financially Sound Company?
2019-05-28 08:55:12 | Here's Why You Should Retain NuVasive NUVA Stock for Now
2019-05-28 08:06:18 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-05-21 09:28:01 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-05-14 09:30:01 | VREX vs. NUVA: Which Stock Is the Better Value Option?
2019-05-07 08:06:28 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-05-06 16:05:00 | NuVasive To Present At The Bank of America Merrill Lynch Healthcare Conference 2019
2019-05-06 08:20:01 | How NuVasive, Inc. NASDAQ:NUVA Can Impact Your Portfolio Volatility
2019-05-02 12:00:09 | Edited Transcript of NUVA earnings conference call or presentation 1-May-19 8:30pm GMT
2019-05-02 11:37:03 | NuVasive NUVA Q1 Earnings Top Estimates, Margins Strong
2019-05-02 05:35:09 | NuVasive Inc NUVA Q1 2019 Earnings Call Transcript
2019-05-01 20:05:00 | NuVasive Straightens Up to Start 2019
2019-05-01 18:05:10 | NuVasive NUVA Q1 Earnings and Revenues Top Estimates
2019-05-01 16:55:37 | NuVasive: 1Q Earnings Snapshot
2019-05-01 16:02:00 | NuVasive Announces First Quarter 2019 Financial Results
2019-05-01 11:53:26 | A Preview Of NuVasive's Q1 Earnings
2019-04-30 08:06:23 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-04-29 09:45:56 | Is NuVasive, Inc. NUVA A Good Stock To Buy?
2019-04-24 10:33:02 | NuVasive NUVA Reports Next Week: Wall Street Expects Earnings Growth
2019-04-15 16:05:00 | NuVasive Announces Conference Call And Webcast Of First Quarter 2019 Results
2019-04-09 10:51:01 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-04-05 08:30:00 | NuVasive LessRay® Platform Wins Top Honor At 2019 Edison Awards
2019-04-02 10:50:02 | NuVasive NUVA Completes First COHERE XLIF Case in U.S.
2019-04-01 08:30:00 | NuVasive Proprietary Porous PEEK™ Technology Used In First XLIF® Spine Surgery Cases
2019-03-22 09:30:01 | NuVasive NUVA Down 1% Since Last Earnings Report: Can It Rebound?
2019-03-12 15:30:51 | Options Bears Jump on Battered NuVasive Stock
2019-03-12 10:31:46 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-03-06 13:39:00 | Why NuVasive Stock Rose 18% in February
2019-03-06 07:55:00 | Research Report Identifies E*TRADE Financial, Kennedy-Wilson, Alteryx, PTC Therapeutics, Ocean Power Technologies, and NuVasive with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
2019-03-05 16:05:00 | NuVasive To Participate In Cowen And Company 39th Annual Health Care Conference
2019-02-22 07:50:12 | NuVasive NUVA Q4 Earnings Beat Estimates, Margins Fall
2019-02-21 16:05:00 | NuVasive To Present At 8th Annual Leerink Partners Global Healthcare Conference
2019-02-21 14:17:47 | NuVasive NUVA Q4 2018 Earnings Conference Call Transcript
2019-02-21 05:58:03 | Edited Transcript of NUVA earnings conference call or presentation 20-Feb-19 9:30pm GMT
2019-02-20 18:21:00 | NuVasive Overcomes Industry Headwinds to Finish 2018 Strong
2019-02-20 17:40:10 | NuVasive NUVA Q4 Earnings and Revenues Top Estimates
2019-02-20 16:34:26 | NuVasive: 4Q Earnings Snapshot
2019-02-20 16:02:00 | NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results